FADD Gene - Fas Associated via Death Domain

Key adaptor protein in apoptosis and immune signaling

Gene Information Card

Symbol FADD
Full Name Fas Associated via Death Domain
Gene Type protein-coding
Chromosomal Location 11q13.3
NCBI Gene ID 8772 ncbi.nlm.nih.gov/gene/8772
Ensembl ID ENSG00000168040
UniProt ID Q13158
OMIM ID 602457
HGNC ID 3573
Aliases GIG3, MORT1, FADD protein

Description

The FADD (Fas Associated via Death Domain) gene encodes a death domain-containing adaptor protein that mediates apoptotic signaling through death receptors such as Fas (CD95) and TRAIL receptors. FADD recruits caspase-8 to form the death-inducing signaling complex (DISC), initiating the extrinsic apoptosis pathway. It also plays roles in non-apoptotic processes including cell proliferation, inflammation, and innate immunity.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Autoimmune lymphoproliferative syndrome (ALPS) type 1B Loss-of-function mutations in FADD impair Fas-mediated apoptosis, leading to defective lymphocyte homeostasis and accumulation of autoreactive cells. ClinVar, OMIM
Head and neck squamous cell carcinoma FADD gene amplification and overexpression correlate with poor prognosis and resistance to apoptosis. COSMIC, NCBI
Colorectal cancer FADD mutations and altered expression contribute to tumor progression and chemoresistance. COSMIC, NCBI
Hepatocellular carcinoma FADD downregulation is associated with evasion of apoptosis and metastasis. NCBI, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Lymph node 28.5 High
Spleen 25.3 High
Bone marrow 20.1 High
Lung 12.4 Medium
Liver 8.7 Medium
Brain 3.2 Low
Cell Line Expression
Cell Line nTPM Notes
Jurkat (T-cell leukemia) 35.2 High expression; used in apoptosis studies
HeLa (cervical carcinoma) 22.8 Moderate expression
HEK293 (embryonic kidney) 18.5 Moderate expression
MCF7 (breast carcinoma) 12.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.1% Loss of start codon; likely loss of function
c.194C>T (p.Pro65Leu) Missense <0.1% Impaired DISC formation; associated with ALPS
c.466G>A (p.Glu156Lys) Missense <0.1% Reduced caspase-8 recruitment
Amplification (11q13.3) Copy number gain 5-10% in HNSCC Overexpression; oncogenic
Mutation functional classification

Loss of Function (LOF)

Missense or nonsense mutations that impair FADD protein expression or disrupt death domain interactions, leading to defective apoptosis and immune dysregulation (e.g., ALPS).

Gain of Function (GOF)

Gene amplification or overexpression in cancers such as head and neck squamous cell carcinoma, promoting cell survival and proliferation.

Dominant Negative (DN)

Certain missense mutations (e.g., p.Pro65Leu) produce a truncated or misfolded protein that interferes with wild-type FADD function in DISC assembly.

Pathways

Fas signaling pathway (CD95)
TRAIL signaling pathway
Extrinsic apoptosis pathway
Death-inducing signaling complex (DISC) assembly
NF-kappa B signaling (non-canonical)

Protein Summary

The FADD protein (208 amino acids, ~23 kDa) contains an N-terminal death effector domain (DED) and a C-terminal death domain (DD). Through its DD, FADD binds to the cytoplasmic tail of death receptors (e.g., Fas, TRAIL-R1/R2), and via its DED, it recruits procaspase-8/10 to form the DISC. This triggers caspase-8 autoactivation and downstream executioner caspases, leading to apoptosis. FADD also participates in non-apoptotic functions including regulation of NF-κB, cell cycle, and innate immune responses.

Related Products

Product name Cat.No. Species Gene ID
FADD Knockout HEK293 Cell Line EDJ-KQ1473 Human 8772 Details Get a Quote
FADD Knockout A-549 Cell Line EDJ-KQ21049 Human 8772 Details Get a Quote
FADD Knockout HCT 116 Cell Line EDJ-KQ21050 Human 8772 Details Get a Quote
FADD Knockout HeLa Cell Line EDJ-KQ21051 Human 8772 Details Get a Quote
Fadd Knockout 32D Cell Line EDJ-KZ231 Mouse 14082 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: